Trials / Recruiting
RecruitingNCT06837506
Ultrasound Guided Rectus Sheath Block Versus Intrathecal Morphine for Postoperative Analgesia in Patients Undergoing Open Total Abdominal Hysterectomy
Ultrasound Guided Rectus Sheath Block Versus Intrathecal Morphine for Postoperative Analgesia in Patients Undergoing Open Total Abdominal Hysterectomy: A Randomized Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to compare the effectiveness and safety of ultrasound-guided rectus sheath block versus intrathecal morphine for postoperative analgesia in patients undergoing open total abdominal hysterectomy.
Detailed description
Effective postoperative analgesia is crucial for enhancing recovery and patient satisfaction following major surgical procedures, such as total abdominal hysterectomy (TAH). Rectus sheath block (RSB), an ultrasound-guided regional anesthesia technique, involves the injection of local anesthetic into the rectus sheath, providing analgesia to the anterior abdominal wall. RSB is used to block the sensory nerves of the anterior abdominal wall and thereby contributing to pain relief after lower abdominal surgeries. Intrathecal morphine (ITM) provides a highly effective method of analgesia by delivering the medication directly into the cerebrospinal fluid (CSF).
Conditions
- Ultrasound
- Rectus Sheath Block
- Intrathecal Morphine
- Postoperative Analgesia
- Total Abdominal Hysterectomy
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rectus sheath block | Patients will receive rectus sheath block (20 ml bilaterally, bupivacaine 0.25%) after induction of general anesthesia. |
| DRUG | Intrathecal morphine | Patients will receive 150 µg intrathecal morphine after induction of general anesthesia. |
Timeline
- Start date
- 2025-02-20
- Primary completion
- 2025-08-01
- Completion
- 2025-08-01
- First posted
- 2025-02-20
- Last updated
- 2025-02-21
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06837506. Inclusion in this directory is not an endorsement.